Medicinal preparation for treating chronic pelvic inflammation

A technology for chronic pelvic inflammatory disease and pharmaceutical preparations, which can be used in drug combinations, medical preparations containing active ingredients, and sexually transmitted diseases. Good, non-toxic effect

Inactive Publication Date: 2014-06-04
范冬梅
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Gynecological examination can touch different degrees of inflammatory masses in the pelvic cavity, which brings great inconvenience to the work and life of patients
At present, antibacterial and anti-inflammatory drugs of Western medicine are mainly used to treat this disease. Although the condition is temporarily

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0011] Example 1 Preparation of a pharmaceutical preparation for the treatment of chronic pelvic inflammatory disease

[0012] The formula is: Polygonatum 25g, Poria cocos 25g, Agrimony 25g, Cassia seed 20g, Aster twig 20g, Artemisia argyi 20g, Angelica dahurica 20g, Rhizoma Cyperi 20g, Chinese rose 15g, Suanzaoren 15g, Shayuanzi 15g, Fangfeng 10g, Lobelia 10g , Codonopsis 10g, Milky White Fragrant Green 10g, Guizhi 10g.

[0013] The preparation method is as follows: taking various raw materials, pulverizing them into powder, passing through a 200-mesh sieve, mixing to obtain the medicine powder, and putting them into capsules to make capsules.

[0014] During treatment, take it orally, once a day in the morning and evening, take about 5g each time (calculated according to the quality of the medicine powder), 15 days is a course of treatment, and generally 2 to 5 courses of treatment can be cured.

Embodiment 2

[0015] Example 2 Preparation of a pharmaceutical preparation for the treatment of chronic pelvic inflammatory disease

[0016] The formula is: Polygonatum 22g, Poria cocos 22g, Agrimony 28g, Cassia seed 23g, Aster twig 18g, Artemisia argyi 18g, Angelica dahurica 23g, Rhizoma Cyperi 23g, Chinese rose 12g, Suanzaoren 12g, Shayuanzi 18g, Fangfeng 13g, Lobelia 8g , Codonopsis 8g, Milky White Fragrant Green 13g, Guizhi 13g.

[0017] The preparation method is as follows: take each raw material medicine, pulverize it into powder, pass through a 200-mesh sieve, mix to obtain the medicine powder, and make a tablet.

Embodiment 3

[0018] Example 3 Preparation of a pharmaceutical preparation for the treatment of chronic pelvic inflammatory disease

[0019] The formula is: Polygonatum 28g, Poria cocos 28g, Agrimony 22g, Cassia seed 18g, Aster twig 23g, Artemisia argyi 23g, Angelica dahurica 18g, Rhizoma Cyperi 18g, Rose 18g, Suanzaoren 18g, Shayuanzi 12g, Fangfeng 8g, Lobelia 13g , Codonopsis 13g, Milky White Fragrant Green 8g, Guizhi 8g.

[0020] The preparation method is as follows: take each raw material medicine, crush it into powder, pass through a 200-mesh sieve, and mix to obtain the medicine powder.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicinal preparation for treating chronic pelvic inflammation. The medicinal preparation is prepared from the following bulk drugs: 20-30g of rhizome rhizome polygonati, 20-30g of poria cocos, 20-30g of agrimonia pilosa, 15-25g of semen cassiae, 15-25g of aster poliothamnus diels, 15-25g of folium artemisiae argyi, 15-25g of radix angelicae, 15-25g of rhizome cyperi, 10-20g of China rose, 10-20g of spina date seed, 10-20g of flatstem milkvetch seed, 5-15g of radices sileris, 5-15g of Chinese lobelia, 5-15g of codonopsis pilosula, 5-15g of milky white pearleverlasting herb and 5-15g of cassia twig. The preparation method comprises the steps of taking respective bulk drugs, grinding to be powdery, sieving with 200 meshes, mixing and preparing into powder, capsula, dissolved medicine, tablet or pills. The medicinal preparation is orally taken once every morning and evening by about 5g, a course of treatment includes 15 days and generally the disease can be cured completely after 2-5 courses of treatment.

Description

technical field [0001] The invention relates to a pharmaceutical preparation for treating chronic pelvic inflammatory disease. Background technique [0002] When the female internal genitalia (uterus, ovary, fallopian tube) and its surrounding tissues, pelvic cavity, and peritoneum are inflamed, it is called pelvic inflammatory disease. Chronic pelvic inflammatory disease is caused by acute pelvic inflammatory disease that has not been completely cured or the disease is prolonged. It can happen when the time is poor. Chronic pelvic inflammatory disease has lower abdominal pain and falling, accompanied by lumbosacral pain, increased leucorrhea, and irregular menstruation. Gynecological examination can touch different degrees of inflammatory masses in the pelvic cavity, which brings great inconvenience to the work and life of patients. At present, antibacterial and anti-inflammatory drugs of Western medicine are mainly used to treat this disease. Although the condition is te...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8969A61K9/14A61P15/00
Inventor 刘秀香赵国英吴玉梅
Owner 范冬梅
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products